Omics Lab Services Market Report 2026

The omics lab services market size has grown rapidly in recent years. It will grow from $109.47 billion in 2025 to $126.6 billion in 2026 at a compound annual growth rate (CAGR) of 15.7%. The growth in the historic period can be attributed to expansion of life sciences research activities, growth of pharmaceutical r&d pipelines, increasing availability of omics technologies, rising outsourcing of laboratory services, expansion of academic and clinical research collaborations.

The omics lab services market size is expected to see rapid growth in the next few years. It will grow to $224.14 billion in 2030 at a compound annual growth rate (CAGR) of 15.4%. The growth in the forecast period can be attributed to increasing adoption of personalized medicine research, rising investments in systems biology, expansion of ai-enabled bioinformatics tools, growing demand for end-to-end omics solutions, increasing focus on data-driven drug discovery. Major trends in the forecast period include increasing demand for integrated multi-omics analysis, growing adoption of contract research services, expansion of bioinformatics-driven data interpretation, rising use of high-throughput analytical platforms, enhanced focus on translational research support.

The rising prevalence of genetic diseases is expected to drive the growth of the omics lab services market going forward. Improved genomic technologies have increased detection of genetic disorders. Omics lab services analyze complex biological data to enable early diagnosis and personalized treatment. For instance, cystic fibrosis patient registrations increased in the UK between 2022 and 2023. Therefore, rising genetic disease prevalence is driving the growth of the omics lab services market.

Leading companies operating in the omics lab services market are focusing on developing innovative solutions such as high-throughput genomics to accelerate biomedical research and precision medicine. High-throughput genomics involves the use of advanced technologies to rapidly sequence and analyze large volumes of DNA or RNA, enabling efficient large-scale genetic studies. For instance, in September 2024, The Translational Genomics Research Institute (TGen), a US-based nonprofit medical research institute, launched the Center for Spatial Multi-Omics (COSMO). The center delivers high-resolution whole-transcriptome data using sequencing-based Visium HD combined with histological staining and offers tissue processing services such as Tissue Microarray (TMA) construction for cost-effective, multiplexed sample analysis. Its customizable platforms, supported by machine learning-driven cell segmentation, enable detailed visualization and spatial mapping of molecular data within intact tissues, supporting progress in precision medicine and disease research.

In July 2024, Anacura, a Belgium-based healthcare and life sciences company, acquired ohmX.bio NV for an undisclosed amount. Through this acquisition, Anacura aims to expand its multi-omics capabilities to accelerate drug discovery and diagnostic development while strengthening its position within the Ghent biotech ecosystem and broader pharmaceutical research markets. ohmX.bio NV is a Belgium-based biotechnology company specializing in genomics, transcriptomics, and epigenomics.

Major companies operating in the omics lab services market are Thermo Fisher Scientific Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Revvity Inc., QIAGEN N.V., Novogene Co. Ltd., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Macrogen Inc., MedGenome Labs Ltd., Metabolon Inc., Zymo Research Corporation, CD Genomics, BaseClear B.V., Strand Life Sciences Pvt. Ltd., Sengenics Corporation Pte Ltd., Psomagen Inc., Biocrates Life Sciences AG, Creative Proteomics.

North America was the largest region in the omics lab services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the omics lab services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the omics lab services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the omics lab services market by increasing costs of imported sequencing platforms, mass spectrometers, reagents, chromatography systems, and advanced bioinformatics infrastructure. Pharmaceutical and biotechnology companies in North America and Europe are most affected due to dependence on imported analytical technologies, while Asia-Pacific faces cost pressures on service scalability. These tariffs are increasing service pricing and project timelines. However, they are also encouraging domestic instrument manufacturing, regional service expansion, and localized bioinformatics capability development.

The omics lab services market research report is one of a series of new reports that provides omics lab services market statistics, including omics lab services industry global market size, regional shares, competitors with a omics lab services market share, detailed omics lab services market segments, market trends and opportunities, and any further data you may need to thrive in the omics lab services industry. This omics lab services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Omics lab services encompass a broad range of laboratory offerings dedicated to analyzing the complete spectrum of biological molecules within a biological system. These services aim to provide a comprehensive understanding of how molecular components are structured, regulated, and interact to influence the form and function of living organisms.

The primary types of services in omics lab services are genomics, transcriptomics, proteomics, metabolomics, and epigenomics. Genomics focuses on studying the complete DNA content of an organism, including gene functions and interactions. These services are delivered through models such as contract services, in-house services, consultative offerings, collaborative research, and customized solutions and utilize technologies including next-generation sequencing (NGS), microarray, mass spectrometry, chromatography, and bioinformatics tools. Applications include drug discovery, diagnostics, personalized medicine, and others, serving end-users such as research institutes, pharmaceutical companies, biotechnology firms, academic institutions, and clinical laboratories.

The omics lab services market includes revenues earned by entities by providing services such as whole genome sequencing, expression profiling, protein identification, biomarker discovery, and chromatin immunoprecipitation analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.